Myrexis, Inc.
MYRX
$0.007
$0.000.00%
OTC PK
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 93.14% | -99.83% | -- | -- | -13,789.29% |
| Gross Profit | -93.14% | 99.83% | -- | -- | 13,789.29% |
| SG&A Expenses | -90.06% | -54.24% | 23.25% | -20.98% | -44.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 115.12% | -77.52% | -36.25% | -56.75% | -115.60% |
| Operating Income | -115.12% | 77.52% | 36.25% | 56.75% | 115.60% |
| Income Before Tax | 96.58% | 69.71% | 35.95% | 60.16% | 44.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 96.58% | 69.71% | 35.95% | 60.16% | 44.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 96.58% | 69.71% | 35.95% | 60.16% | 44.69% |
| EBIT | -115.12% | 77.52% | 36.25% | 56.75% | 115.60% |
| EBITDA | -111.84% | 76.90% | 35.46% | 57.66% | 121.21% |
| EPS Basic | 97.34% | 73.17% | 37.54% | 61.22% | 46.47% |
| Normalized Basic EPS | -111.48% | 79.91% | 37.42% | 57.87% | 115.82% |
| EPS Diluted | 97.34% | 73.17% | 37.54% | 61.22% | 46.47% |
| Normalized Diluted EPS | -111.48% | 79.91% | 37.42% | 57.87% | 115.82% |
| Average Basic Shares Outstanding | 28.88% | 12.89% | 2.55% | 2.76% | 3.33% |
| Average Diluted Shares Outstanding | 28.88% | 12.89% | 2.55% | 2.76% | 3.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |